The largest database of trusted experimental protocols

14 protocols using cd34 microbead kit ultrapure human

1

Isolation and Expansion of Human CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Citric acid (ACS reagent, ≥99.5%), Diethylentriamine (DETA, 99%), L-Glutamine-Penicillin-Streptomycin solution, Dulbecco’s Phosphate Buffered Saline (DPBS), Float-A-Lyzer dialysis devices (100–500 Da), human serum albumin, EDTA, Selenoprotein-AF647 antibodies and sterile filters (200 nm) were obtained from VWR and antibodies against CD45-FITC/CD34-PE, CD34-APC and the FITC Annexin V Apoptosis Detection Kit I were purchased from BD biosciences. Stem SPAN™ SFEM II medium, Stem SPAN™ CD34+ Expansion Supplement (10x) and Lymphoprep™ solution were bought at STEMCELL™ Technologies and microwave reaction vessels were obtained from CEM GmbH. The CD34 MicroBead Kit UltraPure human, MACS LS columns and 30 pre separation filters were purchased from Miltenyi Biotec and the Fix and Perm Kit was bought from Thermo Fisher Scientific. Separation buffer was prepared freshly by supplementing 500 ml DPBS with 1.5 ml 5% human serum albumin and 1.5 ml 50 mM EDTA.
+ Open protocol
+ Expand
2

CD34+ Cell Enrichment using MACS

Check if the same lab product or an alternative is used in the 5 most similar protocols
esCAR T cells were purified using CD34 MicroBead kit UltraPure human (Miltenyi Biotec, cat# 130-100-453) with the MACS-LD column (Miltenyi Biotec, cat# 130-042-901) according to the manufacturer’s instructions. The extent of enrichment was checked by flow cytometry on a BD Accuri C6 flow cytometer.
+ Open protocol
+ Expand
3

Isolation and Characterization of Immune Cell Subsets

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were separated by Histopaque (Histopaque 1077, Sigma-Aldrich) density gradient centrifugation from leukocyte-rich plasma named Buffy Coat, which was provided by the blood bank from healthy human donors. CD4 + CD25 + Treg cells, CD4 + Th cells, and CD8 + CTLs were isolated from PBMCs with magnetic bead-coupled antibodies (Miltenyi Biotec) and phenotyped with fluorochrome-coupled antibodies by flow cytometry as described (Supplement Fig. S1)59 (link). CD34-positive progenitor cells were isolated from PBMCs with the CD34 MicroBead Kit, UltraPure human (Miltenyi Biotec) (Supplement Fig. S2a and S2b).
PBMCs were cultivated in six-well Corning plates with RPMI and 1.5% autologous serum. Autologous serum was separated in the process of Ficoll (Histopaque 1077) density gradient centrifugation from buffy coat. After 30 min of cultivation (37 °C at 5% CO2), monocytes attached to the bottom of the plates, whereas peripheral blood lymphocytes remained in the supernatant. The amount of CD3 + T cells within the PBLC population ranged between 70% and 85% (Supplement Figure S3a).
Jurkat cells (ACC 282, DSMZ) were cultivated in RPMI medium (Gibco Life Technologies) containing 10% fetal calf serum (Biochrome AG). Cells (2.5 × 105) were irradiated and cultivated per well of a 12-well plate for cell death analysis.
+ Open protocol
+ Expand
4

Xenotransplantation of Edited HSPCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Xenotransplantation experiments were carried out as previously described (Métais et al., 2019 (link)). Briefly, ZNF410 edited or control CD34+ HSPCs were administered at a dose of 0.4 million per NBSGW mouse (The Jackson Laboratory) by tail-vain injection at aged 8–12 weeks. Chimerism post-transplantation was assessed by flow analysis at 8 weeks in the periphery and at 16 weeks in the bone marrow at the time of euthanasia. Cell linage composition was determined in the bone marrow using human-specific antibodies, and different lineages were sorted by a FACSAria III cell sorter. CD34+ HSPCs were isolated with magnetic beads using the human-specific CD34 MicroBead Kit UltraPure, human (Miltenyi Biotec Inc).
+ Open protocol
+ Expand
5

Isolation and In Vitro Culture of Leukemic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
AML BM samples were collected at diagnosis at the Department of Biomedicine and Prevention at the University of Rome Tor Vergata, after obtaining informed consent from all patients and approval of the study by the IRB of Policlinico Tor Vergata, Rome, in accordance with the Helsinki Declaration of 1975, as revised in 2013. CD34+ LSCs from patient BM samples and CD34+ HSCs from healthy donors, were isolated by positive selection with CD34 MicroBead Kit UltraPure human (Miltenyi Biotec) then cultured and treated in vitro at a concentration of 10.000 cells/ml in STEM SPAN Leukemic cell expansion medium.
+ Open protocol
+ Expand
6

Humanized Mice for Cancer Immunotherapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical cord blood-derived mononuclear cells were purified from healthy donors by density-gradient centrifugation using Ficoll Paque PLUS at a density of 1.068 g/mL (Miltenyi Biotec). CD34 + stem cells were extracted from cord blood-derived mononuclear cells using CD34 MicroBead Kit UltraPure human (Miltenyi Biotec). To obtain CD34 + humanized mice, 4-to 5-week-old NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ (NSG) mice were treated with 1.5 Gy gamma radiation 12-24 hours before implantation of 5 × 10 4 freshly isolated CD34 + cells via tail vein. Engraftment of human immune cells was monitored by means of flow cytometry, with >25% human CD45 + cells in each mouse. After 16 weeks, HCT116 cells with single guide RNA negative control and ALKBH5-KO were subcutaneously injected into CD34 + humanized mice (1 × 10 7 cells/mouse). Tumor size and immune cell infiltration were analyzed. Additional methods are provided in the Supplementary Material.
+ Open protocol
+ Expand
7

Isolation of CD34+ Cells from Cryopreserved UCB

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved UCB MNC were thawed in low glucose Dulbecco’s Modified Eagle’s Medium (DMEM) (Thermo Fisher Scientific) containing 20% fetal bovine serum (FBS) (Thermo Fisher Scientific) and 1% Antibiotic-Antimycotic (Thermo Fisher Scientific) (DMEM-20%FBS) supplemented with 10 μg/mL DNase I (Sigma-Aldrich). Cells were washed with MACS buffer and CD34+ cell selection was performed using a Human CD34 MicroBead Kit UltraPure (Miltenyi Biotec, Germany), following manufacturer’s instructions.
+ Open protocol
+ Expand
8

Isolation and Characterization of CD34+ Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All human UCB samples were obtained from Guangdong Cord Blood Bank. Written informed consent was obtained from each donor. The use of these samples in this study was approved by the Committee for the Ethical Review of Research Involving Human Subjects at Guangdong Cord Blood Bank. CD34+ cells were collected using human CD34 MicroBead Kit UltraPure (Miltenyi Biotec, 130-100-453). The purity was > 90%, and the viability of the cells was > 95%. The remaining fraction was identified as CD34- cells.
+ Open protocol
+ Expand
9

CD34+ HSC Isolation and Cryopreservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mononuclear cells were isolated from blood products by Ficoll‐Paque density gradient centrifugation (Biocoll; Biochrom, Germany). CD34+ HSC were isolated by positive magnetic selection (human CD34 MicroBead Kit UltraPure; Miltenyi Biotec, Germany) according to the manufacturer's instructions. Cryopreservation was performed in human serum supplemented with 10% dimethyl sulfoxide (both from Sigma‐Aldrich, Germany) at a cooling rate of 1°C/min.
+ Open protocol
+ Expand
10

Cortactin Depletion in Leukemia Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell lines REH and RS4:11 and stromal HS-5 and OP9 cells were obtained from ATCC, were free of mycoplasma, and cultured according to the provided protocols. Stable cortactin-depleted REH cells were generated by lentiviral infection using pLentiCRISPRv2 vector (Plasmid #52961, Addgene, Cambridge, MA), and the following gRNA sequences: CTTN-2 ATCGGCCCCCGCGTCATCCT; and CTTN-3 GTCCATCGCCCAGGATGACG. These gRNAs reduced cortactin expression, but CTTN-3 resulted in highest reduction of around 40% (Suppl. Figure 1); thus, these cells were used for all functional experiments. Human umbilical vein endothelial cells (HUVEC) were cultured in EGM-2 medium (Lonza, Switzerland) with 10% FBS. Mononuclear cells from BM specimens from 23 pediatric patients (Suppl. Table 1) were purified by Ficoll-Paque (GE Healthcare) and the CD34+-fraction enriched using the human CD34 MicroBead-Kit-UltraPure (MiltenyiBiotec, Germany). Progenitor cells were identified as LineageCD34+, Pro B cells as CD34+CD19+, and Pre B as CD34CD19+. Mononuclear cells from umbilical cord blood (UCB) were used as control. CSF was collected after lumbar puncture, cytospinned and fixed with 3% (paraformaldehyde) PFA.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!